Three quarters of a mile from civilization
Views, analysis & commentary - essentially on venture capital & pharmaceutical industry
Showing posts with label
CSR
.
Show all posts
Showing posts with label
CSR
.
Show all posts
Monday, May 6, 2013
Dear HBR, defend your research!
›
In the May 2013 issue of HBR that has a ‘spotlight on entrepreneurship’, Adi Ignatius observes in the very first paragraph of his editoria...
Sunday, March 31, 2013
Factors Influencing the Global Prospects & Investor Attractiveness of Indian Pharmaceutical Industry
›
Most ‘Indian Pharma Outlook’ reports from the likes of McKinsey & PwC almost exclusively focus their policy & regulatory scen...
3 comments:
Thursday, January 31, 2013
IRR v/s Social Impact: Do financial institutions necessarily go through this dilemma?
›
The news on Times of India Social Impact Awards & what Nicolas Aguzin, chairman and CEO of JP Morgan- Asia-Pacific said during his s...
›
Home
View web version
